Bio-Gene Technology (ASX:BGT) Total Assets: A$1.47 Mil (As of Dec. 2025)


What is Bio-Gene Technology Total Assets?

Bio-Gene Technology ASX:BGT Total Assets is A$1.47 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Bio-Gene Technology's Total Assets for the quarter that ended in Dec. 2025 was A$1.47 Mil.

During the past 12 months, Bio-Gene Technology's average Total Assets Growth Rate was -25.80% per year. During the past 3 years, the average Total Assets Growth Rate was 1.70% per year. During the past 5 years, the average Total Assets Growth Rate was -1.90% per year.

During the past 8 years, Bio-Gene Technology's highest 3-Year average Total Assets Growth Rate was 3.60%. The lowest was -7.00%. And the median was -3.30%.

Total Assets is connected with ROA %. Bio-Gene Technology's annualized ROA % for the quarter that ended in Dec. 2025 was -154.64%. Total Assets is also linked to Revenue through Asset Turnover. Bio-Gene Technology's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.

Bio-Gene Technology  (ASX:BGT) Total Assets Explanation

Total Assets is connected with ROA %.

Bio-Gene Technology's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-2.802/( (2.15+1.474)/ 2 )
=-2.802/1.812
=-154.64 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Bio-Gene Technology's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0/( (2.15+1.474)/ 2 )
=0/1.812
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Bio-Gene Technology Total Assets Related Terms

Bio-Gene Technology Total Assets Historical Data

* Premium members only.

The historical data trend for Bio-Gene Technology's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Gene Technology Total Assets Chart

Bio-Gene Technology Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Assets
Get a 7-Day Free Trial 5.00 7.30 3.84 3.16 2.15

Bio-Gene Technology Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.29 3.16 1.87 2.15 1.47

Bio-Gene Technology Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Bio-Gene Technology's Total Assets for the fiscal year that ended in Jun. 2025 is calculated as

Total Assets=Total Equity (A: Jun. 2025 )+Total Liabilities (A: Jun. 2025 )
=1.627+0.523
=2.15

Bio-Gene Technology's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=1.167+0.308
=1.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of A$1.47 Mil mean?
Bio-Gene Technology (ASX:BGT) has a Total Assets of A$1.47 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Bio-Gene Technology and its competitors.
Is Bio-Gene Technology's Total Assets too high?
Bio-Gene Technology's current Total Assets is A$1.47 Mil.
How does Bio-Gene Technology's Total Assets compare to VRTX and REGN?
Bio-Gene Technology's Total Assets of A$1.47 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Bio-Gene Technology and its competitors. Bio-Gene Technology's current Total Assets is A$1.47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Gene Technology stock overvalued right now?
Bio-Gene Technology (ASX:BGT) has a current Total Assets of A$1.47 Mil. The current Total Assets is A$1.47 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Bio-Gene Technology (ASX:BGT), the current Total Assets is A$1.47 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio-Gene Technology Business Description

Address 400 Collins Street, Level 6, Melbourne, VIC, AUS, 3000
Bio-Gene Technology Ltd is an Australian company developing novel bio-insecticides to address the challenges of insecticide resistance and toxicity. Its products are based on a naturally occurring class of compounds to overcome resistance to control pests with minimal impact on human health and the environment. Bio-Gene's products have multiple applications across public health, crop protection, grain storage, and consumer use. The company operates in one business segment, being the conduct of research and development activities in the discovery of novel insecticides.